Clinical trials
Phase 3 Eczema trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 11 |
| Pfizer | 8 |
| Incyte Corporation | 6 |
| Amgen | 3 |
| Pierre Fabre Medicament | 2 |
| Regeneron Pharmaceuticals | 2 |
| Almirall, S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eczema | 33 |
| Dermatitis, Atopic | 30 |
| Dermatitis | 11 |
| Skin Diseases | 8 |
| Pruritus | 5 |
| Genetic Diseases, Inborn | 2 |
| Hypersensitivity | 2 |
| Hypersensitivity, Immediate | 2 |
| Immune System Diseases | 2 |
| Skin Diseases, Eczematous | 2 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.